So what are you doing to help reduce antipsychotic medications in your home?
Currently, long-term care providers are being asked to reduce antipsychotic medications by 25% by the end of 2015, and that number will increase to 30% by the end of 2016.
“This is an area our program is focusing on”, said PGx Medical President, Clay Bullard. The PGx Metabolic Validation Program is a no-cost tool to help guide healthcare professionals when treating patients. The simple buccal swab helps determine which medications are being metabolized in each individual, and psychotropic medications are one of the panels analyzed by the program.
“By determining if an individual even has the ability to metabolize a medication will help you make a decision based on science rather than “trial & error” to see if that person is even capable of receiving therapy from the medication. You save so much time and money by eliminating the guessing game,” said Bullard.
In 2014, Bullard educated Oklahoma State Surveyors and was invited to speak at Provider Training meetings throughout the year.
“Why wouldn’t you use this program if it cost your home nothing and the resident nothing? But the best part is, while the mandate for reducing antipsychotics keeps going up, our tools and resources are becoming more wide-spead. We’re not here to tell you how to do your job, or what medications you should give your residents. We’re here as a resource to help educate and implement a tool that is available for your use to help your residents live longer…better!”
Bullard travels around the country educating healthcare professionals on “Metabolic Validation Testing – Rethinking Your Approach to Pharmaceutical Usage in LTC”
For more information on the PGx Medical Metabolic Validation Program. Or to schedule Clay to speak, contact:
PGx Medical
405-509-5112
info@pgxmed.com
www.pgxmed.com